secwatch.observer — SEC 8-K summary
======================================

Issuer:     COGNITION THERAPEUTICS INC (CGTX)
CIK:        0001455365
Form:       8-K
Filed at:   2023-04-19T23:59:59+00:00
Accession:  0001104659-23-046980
Event type: other
Sentiment:  neutral
Materiality: 0.05
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Cognition Therapeutics files investor presentation; no specific financial or clinical data disclosed.
--------------------------------------------------------------------------------

- Filing under Item 7.01 attaches a presentation for an analyst breakfast meeting in April 2023.
- Presentation exhibit contains only a title slide; no pipeline, financial, or clinical updates are provided.
- No earnings, guidance, or material operational changes are reported in the filing.
- Cognition Therapeutics is a clinical-stage company focused on disease-modifying medicines for degenerative disorders.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1455365/000110465923046980/0001104659-23-046980-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1455365/000110465923046980/tm2313109d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-23-046980

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer